Brain natriuretic peptide plasma levels as a marker of prognosis in patients with community-acquired infection

European Journal of Emergency Medicine

Volumn 17, Issue 5, 2010, Pages 293-295

  Goritsas, Constantin ^a   Fasoulaki, Magdalini ^a   Paissios, Nikolaos P ^a   Giakoumaki, Emilia ^b   Alamanos, Yannis ^c   Nikolaou, Nikolaos I ^b  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b AGIA OLGA HOSPITAL   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

brain natriuretic peptide; cytokines; infection; prognosis; sepsis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ABDOMINAL INFECTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION; LOWER RESPIRATORY TRACT INFECTION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; URINARY TRACT INFECTION;

BIOLOGICAL MARKERS; COMMUNITY-ACQUIRED INFECTIONS; CYTOKINES; FEMALE; GREECE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 77956408298     PISSN: 09699546     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e328332354b     Document Type: Article

References (10)

1. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350:647-654. (Pubitemid 38364623)
2. Doust JA, Pietrzak E, Dobson A, Glasziou PP. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systemic review. BMJ 2005; 330:625-627.
3. Piechota M, Banach M, Irzmanski R, Barylski M, Piechota-Urbanska M, Kowalski J, Pawlicki L. Plasma endothilin-1 levels in septic patients. J Intensive Care Med 2007; 22:232.
4. Witthaut R, Busch C, Fraunberger P,Walli A, Seidel D, Pilz G, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003; 10:1696-1702.
5. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabart S, et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665.
6. Ueda S, Nishio K, Akai Y, Fukushima H, Yueyama T, Kawai Y, et al. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 2006; 26:134-139.
7. Varpula M, Pulkki K, Karlsson S, Ruokonen E, PettiläV. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35:1277-1283.
8. Christ-Crain M, Breidthardt T, Stolz D, Zobrist K, Bingisser R, Miedinger D, et al. Use of B-type natriuretic peptide in the risk stratification of communityacquired pneumonia. J Intern Med 2008; 264:166-176. (Pubitemid 351962572)
9. Nikolaou NI, Goritsas C, Dede M, Paissios NP, Papavasileiou M, Rombola AT, et al. Brain natriuretic peptide increases in septic patients without severe sepsis or shock. Eur J Int Med 2007; 18:535-541.
10. Meyer B, Huelsmann M,Wexberg P, Delle Karth G, Berger R, Moertl D, et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 2007; 35:2268-2273.